Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
Amorim, Sandy, Stathis, Anastasios, Gleeson, Mary, Iyengar, Sunil, Magarotto, Valeria, Leleu, Xavier, Morschhauser, Franck, Karlin, Lionel, Broussais, Florence, Rezai, Keyvan, Herait, Patrice, Kahatt,Langue:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(16)00021-1
Date:
March, 2016
Fichier:
PDF, 661 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
